利用LCD 3D打印模具制备的低成本几何可调PDMS人工晶状体用于犬眼科应用。 机翻

Low-cost geometry-tunable PDMS intraocular lenses fabricated using LCD 3D-printed molds for canine ophthalmic applications.

自动标签待生成
期刊iScience
发表日期2026-10-15
物种犬
DOI10.1016/j.isci.2026.117890
PMID42926869

摘要

This study demonstrates the feasibility of fabricating geometry-tunable polydimethylsiloxane (PDMS) intraocular lens (IOL) prototypes using consumer-grade liquid crystal display (LCD) 3D-printed molds and PDMS casting. A reusable mold fabrication strategy incorporating a PMMA barrier layer successfully eliminated PDMS curing inhibition while preserving the mold geometry for repeated casting. The fabrication workflow accurately replicated a plate-haptic lens with a 6 mm optic and dimensional deviation below 1.5%, while enabling optical power to be tuned from 18 to 42 D by varying mold curvature alone. The fabricated PDMS IOLs exhibited high visible-light transparency (>95%), preliminary focusing ability, resolving power and image contrast comparable to a commercial IOL, acceptable post-treatment cytocompatibility, successful injector-assisted delivery with recovery of the original geometry, and preliminary hydrolytic stability and leachability performance. These results establish a reproducible, low-cost, and customizable fabrication platform for PDMS intraocular lenses and provide a foundation for future optimization toward customizable veterinary ophthalmic applications.

站内已收录开放获取全文,见下方。

全文 开放获取 · cc by-nc 中文机翻

摘要

本研究证明了利用消费级液晶显示器(LCD)3D打印模具和聚二甲基硅氧烷(PDMS)浇铸来制造几何形状可调的PDMS人工晶状体(IOL)原型的可行性。一种结合PMMA阻隔层的可重复使用模具制造策略成功消除了PDMS固化抑制现象,同时保持了模具几何形状以供重复浇铸。该制造流程精确复制了具有6 mm光学区的板式襻晶状体,尺寸偏差低于1.5%,同时仅通过改变模具曲率即可将光焦度从18 D调节至42 D。所制备的PDMS人工晶状体表现出高可见光透明度(>95%)、初步的聚焦能力、与商用人工晶状体相当的分辨力和图像对比度、可接受的处理后细胞相容性、成功的注射器辅助递送并恢复原始几何形状,以及初步的水解稳定性和浸出性表现。这些结果建立了一个可重复、低成本且可定制化的PDMS人工晶状体制造平台,并为未来面向可定制兽医眼科应用的优化奠定了基础。

关键词:人工晶状体,聚二甲基硅氧烷,PDMS,LCD 3D打印,兽医眼科,光焦度调节

引言

在全球范围内,加拿大盲人国家研究所(CNIB)和泰国盲人协会(TAB)等国家级组织为视力障碍者提供导盲犬,使他们能够在我们社会中过上更正常的生活。然而,另一方面,这些犬现在容易罹患失明,这可能对视力障碍者可获得的导盲犬数量产生重大影响。白内障是犬视力障碍和失明最常见的原因之一,其特征是晶状体进行性混浊,阻碍光线传输至视网膜。在一项对2,000只犬的横断面研究中,白内障患病率在9.4 ± 3.3岁时达到50%,所有超过13.5岁的犬均存在一定程度的晶状体混浊。1 犬白内障的形成受多种因素影响,包括衰老、遗传性疾病和代谢紊乱,这些因素可加速晶状体混浊。2 进行性晶状体混浊可导致严重视力障碍、晶状体诱导性葡萄膜炎、青光眼和不可逆性失明,严重影响患病动物的生活质量和日常功能。2,3 因此,迫切需要应对这一挑战。

因此,白内障被认为是犬可预防性失明的主要原因,3 通过超声乳化术手术摘除混浊晶状体后植入人工晶状体(IOL)已被报道可在高达79.2%的病例中恢复功能性视力。2 与无晶状体眼结果相比,IOL植入显著减少了术后眩光并恢复了深度知觉,从而改善了术后视觉表现。4 尽管具有这些临床优势,兽医IOL的可及性和性能仍取决于材料选择、光学设计和制造精度,这些均直接影响手术结果和长期生物相容性。

传统IOL材料,包括聚甲基丙烯酸甲酯(PMMA)和硅弹性体,5 以及丙烯酸聚合物,6 因其光学透明性和已确立的临床性能而被广泛使用。5,6 然而,这些材料在光学透明度、机械柔韧性、可折叠性和长期生物相容性之间存在固有的权衡。6,7 特别是,PMMA等刚性材料需要较大的切口尺寸,6,8 而较软的聚合物可能存在表面相关并发症、蛋白质吸附、细胞黏附9 和炎性沉积物,这些可影响长期光学性能。5,7,10 这些局限性凸显了需要能够平衡光学质量、机械顺应性和生物相容性的替代材料用于兽医应用。

目前的IOL制造依赖于使用PMMA、丙烯酸共聚物或硅弹性体的精密模塑、车削或光刻技术。这些制造工艺在很大程度上受限于材料特定要求和有限的设计灵活性。兽医专用设计进一步受到制造商有限、交货周期长和缺乏定制选项的制约。市售晶状体在范围上仍然有限且基本标准化,限制了根据个体解剖变异定制光学特性的能力。

增材制造的最新进展为光学元件的制造提供了有前景且经济高效的方法。11,12 然而,直接打印的聚合物透镜本质上受到可打印光聚合物或光响应树脂体系的限制。8 此外,打印表面粗糙度会降低光学质量。13,14 另一种方法是使用3D打印进行模具制造,随后用光学适用材料如聚二甲基硅氧烷(PDMS)进行浇铸,从而将几何设计与材料功能分离。15,16 在本研究中,该模具辅助策略被应用于制造几何可调的PDMS人工晶状体原型,使PDMS可作为最终晶状体材料,同时保留3D打印模具制造的设计灵活性,通过改变模具曲率实现18至42 D的光焦度调节。

在本工作中,开发了一种基于PDMS的人工晶状体的低成本方法,以解决表面质量和制造可及性方面的关键挑战。该研究利用消费级液晶显示器(LCD)3D打印模具并结合旋涂表面平滑处理,以提高尺寸保真度和光学表面质量。研究了一种单焦点6 mm板式襻设计,重点探讨几何控制和材料配方如何影响晶状体性能。进行了全面的表征,包括光学评估、成像性能、力学测试、表面润湿性和体外细胞毒性评估。结果证明了具有可调光学性能的PDMS人工晶状体可定制制造平台的可行性。所制造的原型展现出有前景的初步光学、力学和生物学性能,为进一步优化和未来兽医眼科应用奠定了基础。

结果与讨论

人工晶状体材料的选择

人工晶状体制造材料的选择旨在满足光学透明性、小切口植入所需柔韧性、可模塑性和生物相容性的要求。对于模具浇铸晶状体,材料必须在固化后复制曲面光学表面,同时保持可接受的生物学性能。传统人工晶状体材料如PMMA、丙烯酸类和硅酮基聚合物提供了成熟的临床性能,但可能根据其加工路线限制可折叠性、可定制性或表面质量。5,6 表面性质,包括粗糙度和润湿性,也可影响细胞黏附和後囊混浊,需要光滑的复制和可靠的表征。7

选择聚二甲基硅氧烷(PDMS)是因其光学透明性、17 已确立的生物医学用途、18,19 弹性体柔韧性19,20 以及与3D打印模具复制成型的兼容性。15,21 其柔韧性对于可折叠人工晶状体尤为有利,与刚性晶状体相比能够通过更小的切口植入。

Sylgard 184 PDMS(Dow Corning,美国)的基础剂与固化剂重量比在10:1、15:1和20:1之间变化,以在保持光学透明性的同时控制交联密度和力学性能。增加基础剂比例会降低交联密度,导致弹性体网络更软,弹性模量更低,顺应性更高。10:1配方预期提供更高的刚度和结构稳定性,而15:1和20:1配方预期表现出增加的柔韧性,这对于植入过程中的折叠有利。然而,降低交联密度也可能影响其他材料特性,22 包括尺寸稳定性、表面保真度和生物学反应。因此,需要全面评估光学性能、力学行为、表面性质和细胞毒性,以确定在人工晶状体应用中提供适当平衡的配方。

犬人工晶状体的光学和几何设计

选择板式襻构型,其中晶状体的光学部由宽大的板状延伸部而非柔性环形结构支撑,用于在囊袋内固定,以支持晶状体的稳定定位和光学对准。人工晶状体的几何形状如图1所示。

[图:设计的板式襻人工晶状体的几何形状(A)俯视图显示板式襻几何形状,总长12 mm]

论文配图

板式襻人工晶状体术后偏中心(0.12 ± 0.06 mm)和倾斜显著低于C形襻设计(0.22 ± 0.13 mm),改善了囊袋内的光学对准。23 襻厚度设定为1 mm,以提供足够的机械支撑,同时保持植入过程中折叠所需的柔韧性,从而能够通过缩小的手术切口插入。

在光学部和触觉部周边均引入了锐边几何结构。锐利的光学边缘在后囊膜上形成明显的弯折,机械性地阻碍残留晶状体上皮细胞(LECs)的迁移,从而降低后囊膜混浊(PCO)的风险。24 对于触觉部周边,引入了受控的边缘几何结构以调节与囊袋的机械相互作用。过于锐利的边缘可能导致局部应力集中和潜在的组织刺激,而过于圆钝的几何结构则可能降低机械啮合力和位置稳定性。因此,所提出的边缘设计旨在实现足够的机械锚定,同时在囊袋内保持稳定且一致的位置。这两种特征的设计还兼顾了基于PDMS模具的制造工艺兼容性,该工艺要求几何结构能够可靠复制并在脱模时不发生变形或损坏。

模具几何结构与表面优化

开发了一种模具,以实现人工晶状体几何结构的精确复制,并便于PDMS基透镜的受控制造。该设计包含6 mm光学腔、板式触觉部轮廓以及锐边特征。光学腔表面被建模为与目标光学曲率相对应的球面几何结构。所有设计均使用计算机辅助设计(CAD)软件生成,并导出为STEP文件用于增材制造。

模具设计如图2A所示。采用两部分模具配置,以实现完整的透镜腔复制并便于PDMS固化后的可靠脱模。模具中集成了两个通道,一个用作PDMS预聚物的注射口,另一个用作排气口,以最大限度地减少滞留空气并减少腔体填充过程中气泡的形成。模具的两部分固定在刚性夹具内,以确保一致的夹紧力并在浇铸过程中保持对齐,如图2B所示。

[图:人工晶状体模具设计(A)模具设计的俯视图、横截面图和3D渲染图,显示光学部]

论文配图

3D打印模具的表面形貌直接影响复制PDMS透镜的光学质量,在旋涂薄层紫外固化树脂以平滑模具表面之前和之后,通过共聚焦激光扫描显微镜(OLS5100,Olympus Corporation,日本)进行了评估,如图3所示。

[图:紫外树脂旋涂前后3D打印模具表面的共聚焦显微镜图像 反射强度图像(上)]

论文配图

在旋涂紫外固化树脂层之前,模具呈现出由逐层光聚合过程产生的径向周期性表面特征。25 这些特征在反射强度图像中表现为环状图案,在高度轮廓图像中表现为周期性形貌变化,对应于微尺度粗糙度。这种微尺度粗糙度会降低所制造透镜的光学质量。14,26

在以1,000、2,000和3,000 rpm旋涂薄层紫外固化树脂以减少微尺度粗糙度后,高度轮廓中不再观察到周期性表面特征,表明表面得到了有效平滑。然而,反射强度图像中出现了条纹状条带。这些条带与涂层厚度变化引起的薄膜光学干涉有关,而非表面粗糙度所致。随着旋涂速度从1,000 rpm增加到3,000 rpm,条纹间距减小,表明在较高转速下形成了更薄的树脂层。在3,000 rpm条件下中心处观察到的局部像差表明涂层覆盖不足,涂层可能过薄,无法完全平滑3D打印模具表面的残留缺陷。

为量化旋涂对表面质量和几何保真度的影响,对横截面轮廓、曲率测量和表面粗糙度进行了分析。图4A中的横截面轮廓展示了表面轮廓随旋涂速度的变化,主要反映了涂层厚度和整体几何形状的变化。图4B中的曲率测量显示,在较低旋涂速度下,由高度轮廓获得的曲率半径增大,表明由于较厚的涂层层,几何形状偏离设计值而趋向更平坦的光学表面。图4C中的表面粗糙度(Ra)值量化了平滑程度,证实较低旋涂速度可降低粗糙度。综合来看,这些结果揭示了表面平滑与曲率保持之间明显的权衡关系。

[图:紫外树脂旋涂前后模具表面和几何形状的定量分析,以及拉曼表征]

论文配图

旋涂树脂后表面粗糙度降低,同时保持光学透明度,表明所得透镜适用于光学评估。选择1,000 rpm的旋涂速度作为表面平滑与曲率保持之间的最佳平衡,所得模具表面粗糙度(Ramold)为0.40 μm,PDMS人工晶状体粗糙度(RaIOL)为0.36 μm。这些结果表明,所选加工条件为后续光学评估提供了足够的表面质量,同时保持了设计的透镜几何形状。

为进一步验证PMMA阻隔层(该层用于防止PDMS在LCD 3D打印树脂模具上发生固化抑制),采用拉曼光谱(Xplora plus,Horiba,日本)检测浇铸和脱模后所制备的PDMS人工晶状体上是否残留PMMA。对PMMA参比样、PMMA涂层模具以及所制备的PDMS人工晶状体进行了拉曼光谱检测。所制备PDMS人工晶状体的拉曼光谱以PDMS特征谱带为主,而PMMA在约1,725–1,735 cm−1处的特征性酯羰基(C=O)谱带未清晰观察到,如图4D所示。该结果表明,在浇铸和脱模过程中,PMMA阻隔层未可检测地转移至最终晶状体表面。

模具到晶状体的复制保真度

在优化模具表面后,评估了几何特征和表面特征向PDMS人工晶状体转移的保真度。1,000 rpm旋涂模具与复制PDMS人工晶状体的几何和表面参数汇总于表1。在本分析中,Ra500、Ra1,000和Ra2,000分别表示在500、1,000和2,000 μm评价长度上测得的表面粗糙度,以捕捉不同空间尺度上的表面特征。所制备晶状体高度复制了模具几何形状,厚度和曲率半径差异分别为0.74%和1.32%,表明具有高尺寸精度。除几何一致性外,在所有粗糙度评价长度上,PDMS晶状体的表面粗糙度均持续低于相应模具。这种降低证实浇铸过程未引入额外表面伪影,反而有助于进一步表面平滑化。该行为归因于PDMS浇铸的保形特性,使弹性体能够填充表面特征,同时在固化过程中减少小尺度不规则性。

Table 1. Comparison of geometric and surface parameters between the mold and the fabricated PDMS intraocular lens

Table 1 Comparison of geometric and surface parameters between the mold and the fabricated PDMS intraocular lens
ParametersMoldIOLAbsolute difference (%)
Curvature radius (μm)5,913.17 ± 344.705,835.04 ± 330.701.32
Thickness (μm)781.65 ± 14.84775.83 ± 18.710.74
Ra (500 μm)0.40 ± 0.190.36 ± 0.129.62
Ra (1000 μm)1.40 ± 0.281.08 ± 0.5522.63
Ra (2000 μm)2.47 ± 0.671.92 ± 0.9522.14

所制备的PDMS人工晶状体

所开发的制备策略将LCD 3D打印模具与表面改性和PDMS浇铸相结合,以生产所设计的人工晶状体,如图5所总结,打印模具表面首先使用紫外固化树脂涂层进行平滑化,以减少逐层打印过程产生的表面特征并改善所得晶状体的光学质量。

[图:PDMS人工晶状体的制备流程,包括模具制备、PMMA表面改性和PDMS晶状体]

论文配图

将PDMS直接浇铸于光聚合物树脂模具上存在额外挑战,因为树脂中的膦氧化物类光引发剂可能干扰加成型固化PDMS的铂催化氢硅烷化反应,导致固化不完全或不均匀。27,28 因此,在打印模具与PDMS之间引入PMMA界面阻隔层,以尽量减少光引发剂迁移并实现完全交联。使用改性模具,在基础剂与固化剂比例为10:1、15:1和20:1时成功获得PDMS人工晶状体。研究这些配方是因为交联密度的变化会影响固化弹性体的力学性能。29 所制备晶状体在脱模后保留了设计的板式襻几何形状,随后对其尺寸、光学、力学和生物学特性进行了评估。

基于模具的方法还将光学几何形状与最终晶状体材料分离。因此,可以在不改变PDMS配方的情况下以数字化方式修改晶状体几何形状,而模具可以并行制备并重复用于反复浇铸。这为生产几何形状可调的PDMS人工晶状体提供了灵活平台。

光学透明度

在验证几何和表面复制后,评估了所制备晶状体的光学性能,特别关注透明度。所制备的PDMS人工晶状体如图6A所示,呈现清澈透明外观,具有光滑的光学表面和明确的几何形状。为评估基础剂与固化剂比例对光学透明度的影响,检测了以10:1、15:1和20:1(w/w)制备的PDMS晶状体。光学透明度通过紫外-可见分光光度法(Lambda 850+,PerkinElmer,美国)评估,如图6B所示。

[图:所制备PDMS人工晶状体的光学透明度 (A) 所制备的PDMS人工晶状体。(B) P的紫外-可见透射光谱]

论文配图

所有PDMS配方在400–700 nm范围内均表现出超过95%的宽带可见光透过率,各配比之间无显著差异。高透过率与PDMS固有的可见光透明性一致。17 在紫外区域观察到的透过率降低是PDMS的固有特性,这对人工晶状体应用可能是有利的,因为它有助于限制眼组织对紫外线的暴露。未观察到光学透过率随基体与固化剂比例变化的显著趋势,表明所有配方均能持续保持高透明度,支持其用于人工晶状体应用的适用性。

光学力与可调性

为进一步评估所制备镜片的光学性能,对其聚焦行为和光学力进行了表征。开发了一套光学装置以测量轴向强度分布并确定焦点位置,如图7A所示。来自光纤耦合LED(M530F3,Thorlabs,美国)的准直光源经过中性密度(ND)滤光片,用于控制光强度并确保适当的曝光以获得准确的光束轮廓。光束随后通过安装在充满平衡盐溶液(BSS,n = 1.336)的液体比色皿中的PDMS镜片,以模拟眼的屈光环境。实际实验装置如图7B所示,放大视图突出了镜片在比色皿内的定位。透射光束沿光轴使用CMOS相机系统(HY-500M,Hayear,中国)记录,从而能够从轴向强度分布中提取焦点位置。

[图:所制备PDMS人工晶状体的光学表征(A)用于评估聚焦的光学装置示意图]

论文配图

使用该装置,对五种不同曲率半径(R = 3.8、5.5、7.3、8.7和9.6 mm)的PDMS镜片进行了评估,以研究光学力的可调性和可重复性。对于每个曲率半径,制备5个镜片并在相同条件下测量。测量轴向归一化强度分布以确定焦点位置,如图7C所示,其中沿光轴的峰值强度用于获得焦距(f)并计算光学力(D = 1/f)。随着曲率变化观察到焦点位置的系统性偏移,较小的半径产生更靠近镜片的焦点,对应更短的焦距。R = 3.8 mm的镜片表现出约24 mm的焦点位置,对应约42 D的光学力。总体而言,所制备的镜片表现出18至42 D的光学力范围,证明通过几何设计可实现可调性,较小的半径产生更高的光学力,如图7D所示。

为评估所测光学性能的准确性,将结果与基于镜片制造者方程的理论预测进行了比较。30 对于本研究中使用的对称双凸PDMS人工晶状体,在平衡盐溶液(BSS)中的理论光学力(D)可表示为

其中nPDMS和nBSS分别为PDMS(1.45)和BSS(1.336)的折射率,R为曲率半径,d为中心镜片厚度(3.82 mm)。如图7D所示,测量值与理论值之间的密切一致性证实了制备工艺和光学测量方法的可靠性。这表明设计的曲线模具几何形状有效地转移到了PDMS镜片上。该性能满足犬假晶状体矫正的临床所需范围。这种制备方法的一个关键优势是光学力可通过单一几何参数控制,从而能够在无需修改材料系统或加工条件的情况下生产跨越18至42 D的患者特异性镜片。这种灵活性对于解决不同犬种间眼轴长度和角膜曲率的差异尤为重要。

为进一步评估所制备PDMS人工晶状体的成像性能,采用了USAF 1951分辨率靶标,如图7E所示。通过商用人工晶状体和所制备PDMS人工晶状体获得的代表性图像分别如图7F和7G所示。两种镜片均成功分辨了第4组第2元件,对应空间频率为20.16线对/mm,这是本研究中评估的最高空间频率靶标。图像对比度使用迈克尔逊对比度(C)进行量化。

其中Imax和Imin分别为最大和最小强度。所制备的PDMS人工晶状体表现出40.6 ± 1.05%的迈克尔逊对比度,与商用人工晶状体(41.2% ± 1.55%)相当。这些结果表明,所制备的PDMS人工晶状体在测试成像条件下保留了精细空间特征,同时保持了与商用人工晶状体相当的图像对比度。

成像性能

为验证真实图像成像能力,制备了曲率半径较大(R = 20 mm)的PDMS透镜,以提供适合空气中台式成像的较长焦距。将该透镜安装于3D打印支架中,直接置于已拆除镜头的Sony NEX-5T APS-C相机图像传感器前方,形成裸传感器成像配置。在不同物距下拍摄了四个场景,如图8所示,并同时展示了在相似光照条件下使用智能手机拍摄的参考图像。

[图:成像性能比较 制备的PDMS IOL(上)与智能手机参考图像(下)。]

论文配图

PDMS IOL产生了清晰可辨的图像,形状、颜色和文字均可区分。色彩保真度得以保持,与第3.3节报道的高光学透明度一致。未观察到可见雾度或显著散射,证实所制备的透镜表面适用于成像应用。该定性实验证实,所制备的PDMS人工晶状体可作为有效的成像元件发挥作用。

表面润湿性

评估表面润湿性以考察所制备PDMS人工晶状体的界面性质,该性质可影响与眼环境的相互作用。基础剂与固化剂比例为10:1、15:1和20:1制备的PDMS IOL静态水接触角分别为110.59 ± 4.81°、114.58 ± 5.14°和108.32 ± 3.20°,如图9A–9C所示,表明表面 consistently 疏水。这些数值与交联PDMS的固有疏水性一致,且与硅酮基人工晶状体相当。7,31

[图:所制备PDMS人工晶状体的静态水接触角测量 (A) 10:1、(B) 15:1和(C) 20:1基础剂与固化剂比例]

论文配图

力学性能

首先使用拉伸测试仪(EZ-5,Shimadzu,日本)在压缩载荷下评估所制备PDMS人工晶状体的力学性能。该测试评估透镜在植入期间保持足够结构稳定性同时维持足够柔韧性以便折叠的能力。结果包括最大压缩应力、应变和弹性模量,总结于表2。所有配方的最大压缩应力相似,保持在约22 MPa。相比之下,弹性模量随基础剂与固化剂比例增加而降低,从10:1到20:1总体降低约49%。相应地,最大压缩应变增加,表明较高基础剂比例下柔韧性更大。这些结果表明,所制备透镜的压缩力学响应可通过调整PDMS基础剂与固化剂比例进行调控。

Table 2. Compression properties of fabricated PDMS IOLs at different base-to-curing-agent ratios

Table 2 Compression properties of fabricated PDMS IOLs at different base-to-curing-agent ratios
PDMS base-to-curing ratioMax stress (MPa)Max strain (%)Elastic modulus (N/mm 2 )
10:122.23 ± 0.0184.79% ± 2.980.97 ± 0.33
15:122.24 ± 0.0292.99% ± 0.730.91 ± 0.03
20:122.23 ± 0.0299.25% ± 0.890.50 ± 0.16

尽管压缩测试提供了有关整体力学行为的信息,但可折叠人工晶状体的植入还涉及透镜通过注射器 cartridge 时的大量剪切变形。因此,额外进行振荡剪切流变学测量,以评估所制备PDMS IOL在植入相关变形下的粘弹性响应。

为进一步评估所制备PDMS人工晶状体在植入相关剪切变形下的粘弹性,使用流变仪(HAAKE MARS 40,Thermo Fisher Scientific,德国)在剪切模式下于37°C和1 Hz进行振荡流变学测量。代表性流变学参数总结于表3。在低应变下,所有PDMS配方均表现出储能模量(G′)值高于损耗模量(G″),表明以弹性行为为主。10:1配方表现出最高的初始G′(61.06 kPa),其次为15:1(53.48 kPa)和20:1(24.44 kPa)配方,反映了随固化剂含量增加而增高的交联密度。在高应变区域(约50%–60%应变),15:1配方保持最高的G′(27.97 kPa),而10:1和20:1配方分别为13.20 kPa和15.91 kPa。15:1配方在该区域还表现出最高的G″(15.35 kPa),表明在大变形下具有平衡的粘弹性响应,能够维持结构同时耗散变形能量。结合压缩分析,这些发现表明所制备PDMS IOL的力学行为可通过调整基础剂与固化剂比例进行定制。

Table 3. Oscillatory shear rheological properties of fabricated PDMS intraocular lenses at different base-to-curing-agent ratios

Table 3 Oscillatory shear rheological properties of fabricated PDMS intraocular lenses at different base-to-curing-agent ratios
PDMS ratioInitial G′ (kPa)Initial G″ (kPa)G′ at 50–60% strain (kPa)G″ at 50–60% strain (kPa)
10:161.065.6313.2015.21
15:153.484.6827.9715.35
20:124.443.2015.915.96

这些结果表明,PDMS人工晶状体的力学响应可通过调整基液与固化剂的比例进行调节。尽管15:1配方在高应变下提供了最稳定的剪切响应,但综合考虑力学性能和细胞相容性时,10:1配方仍是所测试配方中最合适的候选方案。

为进一步评估所选10:1 PDMS人工晶状体在植入过程中的实际变形响应,使用标准商用人工晶状体注射器 cartridge 进行了注射器递送演示,如图10所示,首先将制作的板式襻PDMS人工晶状体装入注射器 cartridge,置于装载腔内,在递送前折叠,随后通过注射器递送。注射器辅助递送后,晶状体恢复了其整体板式襻几何形状,无可见裂纹、撕裂或大体结构损伤,表明其能够耐受植入过程中遇到的压缩、折叠、剪切和摩擦应力的综合作用。完整的注射器辅助递送过程见视频S1。

[图:制作的PDMS人工晶状体的注射器辅助递送 (A) 装入标准注射器 cartridge 前的制作PDMS人工晶状体]

论文配图

[内容请查看原文]

体外细胞毒性

为确保制作的PDMS人工晶状体适合植入,通过体外细胞毒性测试评估了其生物相容性。对于每种PDMS配方,使用五片制作的晶状体(n = 5)进行提取液制备。提取液按照ISO 10,993–12制备。细胞活力按照ISO 10,993–5指南进行判读,其中细胞活力低于70%被认为在测试提取液条件下提示细胞毒性效应。32不同PDMS配方的细胞活力结果见图11。

[图:后处理前后制作的PDMS人工晶状体的体外细胞毒性 评估细胞活力]

论文配图

如图11所示,对照组显示100.00%细胞活力。在PDMS配方中,10:1基液与固化剂比例显示83.97% ± 15.35%细胞活力,超过70%阈值,表明可接受的细胞相容性。相反,15:1和20:1配方显示较低的细胞活力值,分别为57.61% ± 8.17%和60.48% ± 5.13%,提示在测试条件下潜在的细胞毒性效应。观察到的配方间差异归因于残留的未交联PDMS低聚物的存在。在较高的基液与交联剂比例下,交联减少导致网络中低分子量链的比例增加。这些低聚物可与细胞膜相互作用并诱导细胞毒性反应,33这与15:1和20:1配方观察到的较低活力一致。

经异丙醇(IPA)和去离子(DI)水冲洗后处理后,所有配方的细胞活力均高于ISO 10,993–5接受标准(70%),10:1、15:1和20:1配方的值分别为97.78% ± 3.29%、99.68% ± 11.48%和86.19% ± 10.73%。这些结果表明,初始细胞活力降低主要与可去除的可浸出残留物或未固化表面成分有关,而非固化PDMS网络本身。

水解稳定性测试

水解稳定性测试按照ISO 11,979-534进行,以评估PDMS人工晶状体在加速水相老化下的稳定性。样品在BSS中于95°C孵育30天,相当于约五年的生理老化。34加速老化后,PDMS人工晶状体保持了整体晶状体结构,尽管观察到局部表面改变,包括点蚀样特征、暗色沉积物/变色和线状表面缺陷,如图12所示。此外,老化PDMS人工晶状体的可见光透射率仍为80.94% ± 11.91%,与商用人工晶状体(82.27%)相当,表明加速水解老化后光学透明度基本保持。这些结果表明制作的PDMS人工晶状体在五年等效水解老化后具有初步结构稳定性,尽管在临床应用前仍需进一步的长期稳定性测试。

[图:制作的PDMS人工晶状体的共聚焦显微镜图像 (A) 加速水解老化前和 (B) 后]

论文配图

浸出性测试

可浸出性测试依据 ISO 11,979–5 进行,以评估在模拟提取条件下 PDMS 人工晶状体(IOL)可能释放的化合物。样品在蒸馏水、BSS 和甲苯中于 37°C 提取 72 小时,以代表水性和亲脂性提取环境。提取后的 PDMS IOL 在所有提取介质中暴露后均保持高光学透过率。在 DW、BSS 和甲苯中提取后,可见光透过率分别保持在 91.85% ± 11.47%、99.09% ± 4.99% 和 96.75% ± 8.97%,各提取介质间无统计学显著差异(p = 0.47)。此外,提取介质表现出持续较低的紫外-可见吸光度,且无明显吸收峰,表明在所研究的提取条件下,紫外-可见可检测的可浸出化合物证据极少。这些发现表明,所制备的 PDMS IOL 在水性和亲脂性介质中提取后均保持了其光学性能,同时紫外-可见可检测的可浸出物释放极少。

研究局限性

本工作中所制备的 PDMS IOL 旨在作为展示可定制制造平台可行性的原型,而非作为市售人工晶状体的替代品。与商用 IOL 相比,所制备的 PDMS IOL 在本研究进行的若干评估中表现出相当的初步性能,包括图像分辨率、迈克尔逊对比度、加速水解老化后的光学透明性以及注射器辅助递送。然而,在临床应用之前仍存在若干重要挑战,包括进一步优化表面质量、循环载荷下的长期机械耐久性、全面的生物学评价以及体内验证。尽管存在这些局限性,所提出的制造策略能够无需专用工具即可实现晶状体几何形状的快速数字化定制。可重复使用的模具允许通过简单的几何修改进行可调光学度数(18–42 D)的重复 PDMS 浇铸,促进快速设计迭代,并为生产患者特异性人工晶状体提供了实用平台。总体而言,本工作为基于 PDMS 的人工晶状体建立了一个可定制且可扩展的制造平台,并为眼科植入物的未来发展奠定了基础。

资源可用性

主要联系人

进一步信息和资源的请求应 directed to 并将由主要联系人 Charusluk Viphavakit(charusluk.v@chula.ac.th)予以满足。

材料可用性

本研究未产生新的独特试剂。

数据和代码可用性

[内容请查看原文]

本文报告的数据将应请求由主要联系人共享。

[内容请查看原文]

本文未报告原始代码。

[内容请查看原文]

重新分析本文报告数据所需的任何额外信息可应请求从主要联系人处获取。

致谢

本研究得到泰国第二世纪基金(C2F)、泰国科学研究与创新基金朱拉隆功大学(IND_FF_69_091_2100_014)、111 周年工程研究催化剂基金迈向 U Top 100(038/2569)、泰国国家研究委员会(NRCT)和朱拉隆功大学(N42A690579)、朱拉隆功大学 Rachadapisek Sompote 生物医学材料与器件革命性集成系统工程研究单元基金(BMD-RISE)的资助。

作者贡献

S.R. 撰写 – 原稿、验证、方法学、调查、形式分析、数据管理;A.C. 数据管理;T.L. 数据管理;N.T.、O.J. 和 S.K.M. 监督、撰写 – 审阅和编辑;C.V. 撰写 – 审阅和编辑、监督、项目管理、方法学、资金获取、概念化。

利益声明

作者声明无竞争性利益。

STAR★方法

关键资源表

REAGENT or RESOURCESOURCEIDENTIFIER
Biological sample
L929 mouse fibroblast cellsATCC, USANCTC clone 929 CCL-1
Chemicals
PDMSDow Corning/Dow, USASylgard 184 PDMS kit
Polymethyl methacrylate (PMMA)Sigma-Aldrich/Merck, Germany182265
UV-curable resinElegoo, China8K standard resin
Software and algorithms
CAD softwareOnshape, USAOnshape.com
Slicer softwareElegoo, ChinaChitubox
Image processing softwareImagJFiji
Other
Commercial soft acrylic IOLAJL Ophthalmic S.A., SpainLiocan foldable canine IOL
LCD 3D printerElegoo, ChinaMars 5 Ultra
RheometerThermo Fisher ScientificHAAKE MARS 40
Tensile testerShimadzu, JapanEZ-5
UV/Vis spectrophotometerPerkinElmer, USALambda 850+
Raman spectroscopyHoriba, JapanXplora plus
Confocal laser scanning microscopeOlympus Corporation, JapanOLS5100
CMOS cameraHayear, ChinaHY-500M
Fiber-coupled LEDThorlabs, USAM530F3

方法细节

模具制造和表面制备

模具使用Elegoo Mars 5 Ultra LCD立体光刻打印机(Elegoo,中国)制作,工作波长为405 nm,像素分辨率为18 μm,使用UV光敏聚合物树脂(8K标准树脂,Elegoo,中国)。打印完成后,将模具依次浸入乙醇中清洗,以去除残留的未固化树脂。将一层薄薄的UV固化树脂以1,000 rpm旋涂到模具表面60 s,以减少逐层打印过程引起的表面粗糙度。随后将模具进行UV后固化1 h,并在100°C下热处理1 h,以完成光聚合反应并去除残留的光引发剂。

PMMA阻隔涂层

表面预处理后,在模具表面施加PMMA阻隔层,以防止PDMS的固化抑制。将4%(w/w)PMMA的无水甲苯溶液以1,000 rpm旋涂到模具上30 s,随后在100°C下热处理30 min。

PDMS浇铸与固化

PDMS镜片使用Sylgard 184制作,基础剂与固化剂比例分别为10:1、15:1和20:1(w/w)。每种配方充分混合并在真空下(<600 mmHg)脱气1 h以去除夹带空气。然后将PDMS前体浇铸到组装好的模具腔体中,并在对流烘箱中于100°C热固化2 h。冷却至室温后,小心脱模镜片并准备进行后续表征。

细胞毒性测试

体外细胞毒性测试使用L929小鼠成纤维细胞在朱拉隆功大学牙学院生物材料测试中心进行。每种PDMS配方取五个制作好的镜片用于制备提取液。对于后处理组,制作好的镜片在提取前先用异丙醇冲洗1 min,再用去离子水冲洗1 min。细胞活力按照ISO 10993–5进行判读,其中相对于对照组细胞活力降低超过30%被认为具有细胞毒性。

水解稳定性测试

水解稳定性测试按照ISO 11979-5进行。将制作好的PDMS人工晶状体在BSS中于95°C孵育30天,相当于约五年的生理老化。PDMS人工晶状体在3 mL BSS中提取,而商用人工晶状体对照在0.3 mL BSS中提取。老化后,通过共聚焦显微镜在100×放大倍数下评估镜片形态,并与相同老化条件下的商用人工晶状体进行比较。

浸出性测试

浸出性测试按照ISO 11979–5进行。将制作好的PDMS人工晶状体在蒸馏水、BSS和甲苯中于37°C提取72 h。PDMS人工晶状体在3 mL每种介质中提取,而商用人工晶状体对照在0.3 mL每种介质中提取。溶剂空白在相同条件下制备。提取后,对提取介质和提取后的镜片在300至900 nm范围内进行UV/Vis分光光度分析。评估提取介质中可被UV/Vis检测的浸出化合物,同时评估提取后镜片的光学透明度变化。

定量与统计分析

除非另有说明,定量数据以平均值±标准差(SD)表示。重复数(n)在相应的图注、表注或方法描述中标明。对于光焦度测量,n表示在每个曲率半径下测量的独立制作镜片数;而对于细胞毒性测试,n表示每种PDMS配方用于制备提取液的独立制作镜片数。对于其他测量,n表示独立样本或重复测量,具体见相应章节。

脚注

[内容请查看原文]

参考文献

[内容请查看原文]

关联数据

补充材料

[内容请查看原文]

数据可用性声明

[内容请查看原文]

本文报告的数据将应要求由主要联系人共享。

[内容请查看原文]

本文未报告原始代码。

[内容请查看原文]

重新分析本文报告数据所需的任何额外信息,可应要求从主要联系人处获取。

查看英文原文▾

Summary

This study demonstrates the feasibility of fabricating geometry-tunable polydimethylsiloxane (PDMS) intraocular lens (IOL) prototypes using consumer-grade liquid crystal display (LCD) 3D-printed molds and PDMS casting. A reusable mold fabrication strategy incorporating a PMMA barrier layer successfully eliminated PDMS curing inhibition while preserving the mold geometry for repeated casting. The fabrication workflow accurately replicated a plate-haptic lens with a 6 mm optic and dimensional deviation below 1.5%, while enabling optical power to be tuned from 18 to 42 D by varying mold curvature alone. The fabricated PDMS IOLs exhibited high visible-light transparency (>95%), preliminary focusing ability, resolving power and image contrast comparable to a commercial IOL, acceptable post-treatment cytocompatibility, successful injector-assisted delivery with recovery of the original geometry, and preliminary hydrolytic stability and leachability performance. These results establish a reproducible, low-cost, and customizable fabrication platform for PDMS intraocular lenses and provide a foundation for future optimization toward customizable veterinary ophthalmic applications.

Keywords: intraocular lens, polydimethylsiloxane, PDMS, LCD 3D printing, veterinary ophthalmology, optical power tuning

Introduction

Globally, number of national organizations like Canadian National Institute for the Blind (CNIB) in Canada and Thailand Association of the Blind (TAB) in Thailand provide guide dogs to visually impaired individuals so that they can lead a more normal life in our society. However, on the flip side, these dogs are now prone to blindness, which can have significant impact in the availability of guide dogs for visually impaired individuals. Cataracts are one of the most common causes of visual impairment and blindness in dogs, characterized by progressive opacification of the crystalline lens that obstructs light transmission to the retina. In a cross-sectional study of 2,000 dogs, cataract prevalence reached 50% at 9.4 ± 3.3 years, and all dogs older than 13.5 years had some degree of lens opacity.1 Cataract formation in dogs is influenced by multiple factors, including aging, hereditary conditions, and metabolic disorders, which can accelerate the opacification of the lens.2 Progressive lens opacity can lead to severe visual impairment, lens-induced uveitis, glaucoma, and irreversible blindness, substantially affecting the quality of life and daily functioning of affected animals.2,3 Hence, there is an urgent need to address this challenge.

Cataracts are therefore considered the leading cause of preventable blindness in dogs,3 and surgical removal of the opaque lens through phacoemulsification followed by intraocular lens (IOL) implantation has been reported to restore functional vision in up to 79.2% of cases.2 IOL implantation significantly reduces postoperative glare and restores depth perception compared to aphakic outcomes, thereby improving postoperative visual performance.4 Despite these clinical advantages, the accessibility and performance of veterinary IOLs remain dependent on material selection, optical design, and manufacturing precision, all of which directly influence surgical outcomes and long-term biocompatibility.

Conventional IOL materials, including polymethyl methacrylate (PMMA) and silicone elastomers,5 and acrylic polymers,6 are widely used due to their optical clarity and established clinical performance.5,6 However, these materials present inherent trade-offs among optical transparency, mechanical flexibility, foldability, and long-term biocompatibility.6,7 In particular, rigid materials such as PMMA require larger incision sizes,6,8 while softer polymers may suffer from surface-related complications, protein adsorption, cellular adhesion,9 and inflammatory deposits, which can affect long-term optical performance.5,7,10 These limitations highlight the need for alternative materials that can balance optical quality, mechanical compliance, and biocompatibility for veterinary applications.

Current IOL fabrication relies on precision molding, lathing, or photolithography using PMMA, acrylic copolymers, or silicone elastomers. These manufacturing processes are largely constrained by material-specific requirements and limited design flexibility. Veterinary-specific designs are further constrained by limited manufacturers, long lead times, and a lack of customization options. Commercially available lenses remain limited in range and largely standardized, restricting the ability to tailor optical properties to individual anatomical variations.

Recent advances in additive manufacturing offer promising, cost-effective approaches for the fabrication of optical components.11,12 However, directly printed polymer lenses are inherently limited by the available printable photopolymer or photoresponsive resin systems.8 In addition, printed surface roughness can degrade optical quality.13,14 An alternative approach is to use 3D printing for mold fabrication, followed by casting with optically suitable materials such as polydimethylsiloxane (PDMS), thereby separating geometric design from material functionality.15,16 In the present study, this mold-assisted strategy was applied to fabricate geometry-tunable PDMS intraocular lens prototypes, allowing PDMS to be used as the final lens material while retaining the design flexibility of 3D-printed mold fabrication, which enabled optical power tuning from 18 to 42 D by changing mold curvature.

In this work, a low-cost approach for PDMS-based intraocular lenses is developed to address key challenges in surface quality and manufacturing accessibility. The study utilizes consumer-grade liquid crystal display (LCD) 3D-printed molds with spin-coated surface smoothing to improve dimensional fidelity and optical surface quality. A monofocal 6 mm plate-haptic design is investigated, with emphasis on how geometric control and material formulation influence lens performance. Comprehensive characterization is conducted, including optical evaluation, imaging performance, mechanical testing, surface wettability, and in vitro cytotoxicity assessment. The results demonstrate the feasibility of a customizable fabrication platform for PDMS intraocular lenses with tunable optical properties. The fabricated prototypes exhibited promising preliminary optical, mechanical, and biological performance, providing a foundation for further optimization and future veterinary ophthalmic applications.

Results and discussion

Selection of IOL material

Materials for intraocular lens fabrication were selected to meet requirements for optical transparency, flexibility for small-incision delivery, moldability, and biocompatibility. For mold-cast lenses, the material must reproduce curved optical surfaces while maintaining acceptable biological performance after curing. Conventional IOL materials such as PMMA, acrylic, and silicone-based polymers provide established clinical performance but may limit foldability, customization, or surface quality depending on their processing routes.5,6 Surface properties, including roughness and wettability, can also influence cellular adhesion and posterior capsule opacification, requiring smooth replication and reliable characterization.7

Polydimethylsiloxane (PDMS) was selected due to its optical transparency,17 established biomedical use,18,19 elastomeric flexibility,19,20 and compatibility with replica molding from 3D-printed molds.15,21 Its flexibility is particularly advantageous for foldable IOLs, enabling implantation through smaller incisions compared with rigid lenses.

The Sylgard 184 PDMS (Dow Corning, USA) base-to-curing-agent weight ratio was varied at 10:1, 15:1, and 20:1 to control crosslink density and mechanical properties while maintaining optical transparency. Increasing the base ratio reduces crosslink density, resulting in a softer elastomer network with lower elastic modulus and higher compliance. The 10:1 formulation is expected to provide higher stiffness and structural stability, while the 15:1 and 20:1 formulations are anticipated to exhibit increased flexibility, which is advantageous for folding during implantation. However, reducing crosslink density may also influence other material characteristics,22 including dimensional stability, surface fidelity, and biological response. Therefore, a comprehensive evaluation of optical performance, mechanical behavior, surface properties, and cytotoxicity is required to identify a formulation that provides an appropriate balance for intraocular lens applications.

Optical and geometrical design of the canine intraocular lenses

A plate-haptic configuration, in which the optic of the lens is supported by broad, plate-like extensions rather than flexible loop structures, is selected for fixation within the capsular bag to support stable positioning and optical alignment of the lens. The IOL geometry is illustrated in Figure 1.

[图:Geometry of the designed plate-haptic intraocular lens (A) Top view showing the plate-haptic geometry, 12 mm overall len]

论文配图

Plate-haptic IOLs demonstrate significantly lower postoperative decentration (0.12 ± 0.06 mm) and tilt than C-loop haptic designs (0.22 ± 0.13 mm), improving optical alignment within the capsular bag.23 Haptic thickness is set at 1 mm to provide sufficient mechanical support, while maintaining the flexibility required for folding during implantation, thereby enabling insertion through a reduced surgical incision.

Sharp-edge geometries are incorporated at both the optic and haptic periphery. A sharp optic edge creates a distinct bend in the posterior capsule that mechanically impedes migration of residual lens epithelial cells (LECs), reducing the risk of posterior capsule opacification (PCO).24 For the haptic periphery, a controlled edge geometry is introduced to regulate mechanical interaction with the capsular bag. Excessively sharp edges may lead to localized stress concentration and potential tissue irritation, whereas overly rounded geometries may reduce mechanical engagement and positional stability. The proposed edge design therefore aims to achieve sufficient mechanical anchoring while maintaining stable and consistent positioning within the capsular bag. Both features are also designed to be compatible with PDMS mold-based fabrication, which requires geometries that can be reliably replicated and demolded without deformation or damage.

Mold geometry and surface optimization

A mold was developed to enable accurate replication of the intraocular lens geometry and to facilitate controlled fabrication of PDMS-based lenses. The design incorporates the 6 mm optic cavity, plate-haptic profile, and sharp-edge features. Optical cavity surfaces were modeled as spherical geometries corresponding to the target optic curvatures. All designs were generated using computer-aided design (CAD) software and exported as STEP files for additive manufacturing.

The mold design is illustrated in Figure 2A. A two-part mold configuration was used to enable complete lens cavity replication and to facilitate reliable demolding after PDMS curing. Two channels were integrated into the mold, one serves as the injection port for the PDMS precursor, and the second acts as an air vent to minimize trapped air and reduce bubble formation during cavity filling. The two parts of the mold were secured within a rigid holder to ensure consistent clamping and maintain alignment during casting as shown in Figure 2B.

[图:Intraocular lens mold design (A) Top view, cross-sectional view, and 3D rendering of the mold design, showing the optica]

论文配图

The surface morphology of the 3D-printed molds, which directly influences the optical quality of the replicated PDMS lenses, was evaluated by confocal laser scanning microscopy (OLS5100, Olympus Corporation, Japan) before and after spin-coating a thin UV-curable resin layer to smooth the mold surface, as shown in Figure 3.

[图:Confocal microscopy of 3D-printed mold surfaces before and after UV resin spin coating Reflected-intensity images (top) ]

论文配图

Before spin-coating with the UV-curable resin layer, the molds exhibited radially periodic surface features arising from the layer-by-layer photopolymerization process.25 These features appeared in reflected-intensity images as ring-like patterns and in height-profile images as periodic topographic variations, corresponding to microscale roughness. Such microscale roughness can degrade the optical quality of fabricated lenses.14,26

After spin-coating a thin UV-curable resin layer at 1,000, 2,000, and 3,000 rpm to reduce microscale roughness, the periodic surface features were no longer observed in the height profiles, indicating effective surface smoothing. However, stripe-like bands appeared in the reflected-intensity images. These bands are associated with thin-film optical interference arising from variations in the coating thickness, rather than surface roughness. As the spin speed increased from 1,000 to 3,000 rpm, the fringe spacing decreased, indicating the formation of a thinner resin layer at higher rotational speeds. The localized aberration observed at the center of the 3,000 rpm condition suggests insufficient coating coverage, where the coating layer was likely too thin to completely smooth residual defects from the 3D-printed mold surface.

To quantify the effect of spin-coating on surface quality and geometric fidelity, cross-sectional profiles, curvature measurements, and surface roughness were analyzed. The cross-sectional profiles in Figure 4A illustrate changes in the surface profile with spin speed, primarily reflecting variations in coating thickness and overall geometry. The curvature measurements in Figure 4B show an increase in the radius of curvature obtained from the height profiles at lower spin speeds, indicating a deviation from the designed geometry toward a flatter optical surface due to the thicker coating layer. The surface roughness (Ra) values in Figure 4C quantify the degree of smoothing, confirming that lower spin speeds yield reduced roughness. Together, these results reveal a clear trade-off between surface smoothing and curvature preservation.

[图:Quantitative analysis of mold surface and geometry before and after UV resin spin coating, and Raman characterization of]

论文配图

The surface roughness was reduced after spin-coating the resin, while maintaining optical transparency, indicating that the resulting lenses are suitable for optical evaluation. A spin speed of 1,000 rpm was selected as the optimal balance between surface smoothing and curvature preservation, yielding a mold surface roughness (Ramold) of 0.40 μm and a PDMS intraocular lens roughness (RaIOL) of 0.36 μm. These results demonstrate that the selected processing conditions provide sufficient surface quality for subsequent optical evaluation while maintaining the designed lens geometry.

To further verify the PMMA barrier layer, which was introduced to prevent PDMS curing inhibition on the LCD 3D-printed resin mold, Raman spectroscopy (Xplora plus, Horiba, Japan) was performed to determine whether PMMA residue remained on the fabricated PDMS IOL after casting and demolding. Raman spectroscopy was performed on the PMMA reference, the PMMA-coated mold, and the fabricated PDMS IOL. The Raman spectrum of the fabricated PDMS IOL was dominated by characteristic PDMS bands, while the characteristic ester carbonyl (C=O) band of PMMA at approximately 1,725–1,735 cm−1 was not clearly observed, as shown in Figure 4D. This result suggests that the PMMA barrier layer was not detectably transferred to the final lens surface during casting and demolding.

Mold-to-lens replication fidelity

Following optimization of the mold surface, the fidelity of geometric and surface feature transfer to the PDMS intraocular lenses was evaluated. Geometric and surface parameters of the 1,000 rpm spin-coated mold and the replicated PDMS IOL are summarized in Table 1. In this analysis, Ra500, Ra1,000, and Ra2,000 denote surface roughness measured over evaluation lengths of 500, 1,000, and 2,000 μm, respectively, to capture surface features at different spatial scales. The fabricated lenses closely replicate the mold geometry, with thickness and curvature radius showing differences of 0.74% and 1.32%, respectively, indicating high dimensional accuracy. In addition to geometric agreement, the surface roughness of the PDMS lenses was consistently lower than that of the corresponding molds across all roughness evaluation lengths. This reduction confirms that the casting process does not introduce additional surface artifacts and instead contributes to further surface smoothing. This behavior is attributed to the conformal nature of PDMS casting, which allows the elastomer to fill surface features while reducing small-scale irregularities during curing.

Table 1. Comparison of geometric and surface parameters between the mold and the fabricated PDMS intraocular lens

Table 1 Comparison of geometric and surface parameters between the mold and the fabricated PDMS intraocular lens
ParametersMoldIOLAbsolute difference (%)
Curvature radius (μm)5,913.17 ± 344.705,835.04 ± 330.701.32
Thickness (μm)781.65 ± 14.84775.83 ± 18.710.74
Ra (500 μm)0.40 ± 0.190.36 ± 0.129.62
Ra (1000 μm)1.40 ± 0.281.08 ± 0.5522.63
Ra (2000 μm)2.47 ± 0.671.92 ± 0.9522.14

Fabricated PDMS intraocular lens

The developed fabrication strategy combines LCD 3D-printed molds with surface modification and PDMS casting to produce the designed intraocular lenses, as summarized in Figure 5 the printed mold surface was first smoothed using a UV-curable resin coating to reduce surface features arising from the layer-by-layer printing process and improve the optical quality of the resulting lens.

[图:Fabrication workflow of PDMS intraocular lenses, consisting of mold fabrication, PMMA surface modification, and PDMS len]

论文配图

Direct casting of PDMS against the photopolymer resin mold presents an additional challenge because phosphine oxide-based photoinitiators from the resin can interfere with the Pt-catalyzed hydrosilylation reaction of addition-cure PDMS, resulting in incomplete or non-uniform curing.27,28 PMMA interfacial barrier was therefore introduced between the printed mold and PDMS to minimize photoinitiator migration and enable complete crosslinking. Using the modified molds, PDMS IOLs were successfully obtained at base-to-curing-agent ratios of 10:1, 15:1, and 20:1. These formulations were investigated because variation in crosslink density influences the mechanical properties of the cured elastomer.29 The fabricated lenses retained the designed plate-haptic geometry after demolding and were subsequently evaluated for their dimensional, optical, mechanical, and biological characteristics.

The mold-based approach also separates the optical geometry from the final lens material. Lens geometry can therefore be modified digitally without changing the PDMS formulation, while the molds can be fabricated in parallel and reused for repeated casting. This provides a flexible platform for producing geometry-tunable PDMS IOLs.

Optical transparency

Following the validation of geometric and surface replication, the optical performance of the fabricated lenses was evaluated, with particular focus on transparency. The fabricated PDMS IOL is shown in Figure 6A, exhibiting a clear, transparent appearance with a smooth optical surface and well-defined geometry. To evaluate the effect of the base-to-curing-agent ratio on optical transparency, PDMS lenses prepared at 10:1, 15:1, and 20:1 (w/w) were examined. Optical transparency was assessed by UV-vis spectrophotometry (Lambda 850+, PerkinElmer, USA), as shown in Figure 6B.

[图:Optical transparency of fabricated PDMS intraocular lenses (A) Fabricated PDMS IOL. (B) UV-vis transmission spectra of P]

论文配图

All PDMS formulations exhibited broadband visible-light transmission exceeding 95% across 400–700 nm, with no significant variation among ratios. The high transmission is consistent with the intrinsic visible-light transparency of PDMS.17 The reduced transmission observed in the UV region is an inherent characteristic of PDMS and can be advantageous for intraocular lens applications, as it can help limit UV exposure to ocular tissues. No significant trend in optical transmission with base-to-curing-agent ratio was observed, indicating that high transparency is consistently maintained across all formulations, supporting their suitability for intraocular lens applications.

Optical power and tunability

To further evaluate the optical performance of the fabricated lenses, their focusing behavior and optical power were characterized. An optical setup was developed to measure the axial intensity distribution and determine focal positions, as illustrated in Figure 7A. A collimated light source from a fiber-coupled LED (M530F3, Thorlabs, USA) was directed through a neutral density (ND) filter, which was used to control the light intensity and ensure appropriate exposure for accurate beam profiling. The beam was then passed through the PDMS lens mounted in a liquid-filled cuvette containing balanced salt solution (BSS, n = 1.336) to simulate the refractive environment of the eye. The actual experimental setup is shown in Figure 7B, with an enlarged view highlighting the lens positioning within the cuvette. The transmitted beam was recorded along the optical axis using a CMOS camera system (HY-500M, Hayear, China), enabling extraction of the focal position from the axial intensity profile.

[图:Optical characterization of fabricated PDMS intraocular lenses (A) Schematic of the optical setup for evaluating the foc]

论文配图

Using this setup, PDMS lenses with five different curvature radii (R = 3.8, 5.5, 7.3, 8.7, and 9.6 mm) were evaluated to investigate the tunability and reproducibility of optical power. For each curvature radius, 5 lenses were fabricated and measured under identical conditions. Axial normalized intensity profiles were measured to determine the focal positions, as shown in Figure 7C, where the peak intensity along the optical axis was used to obtain the focal length (f) and calculate optical power (D = 1/f). A systematic shift in focal position was observed with changing curvature, where smaller radii produced focal points closer to the lens, corresponding to shorter focal lengths. The lens with R = 3.8 mm exhibited a focal position of approximately 24 mm, corresponding to an optical power of ∼42 D. Overall, the fabricated lenses exhibited optical powers ranging from 18 to 42 D, demonstrating tunability through geometric design, with smaller radii producing higher optical power, as shown in Figure 7D.

To assess the accuracy of the measured optical performance, the results were compared with theoretical predictions based on the lensmaker’s equation,30 For the symmetric biconvex PDMS IOL used in this study, the theoretical optical power (D) in balanced salt solution (BSS) can be expressed as

D=1nBSS(2(nPDMS−nBSS)R−d(nPDMS−nBSS)2nPDMSR2)

where nPDMS and nBSS are the refractive indices of PDMS (1.45) and BSS (1.336), respectively, R is the radius of curvature, and d is the central lens thickness (3.82 mm). As shown in Figure 7D, close agreement between measured and theoretical values confirm the reliability of both the fabrication process and the optical measurement approach. This indicates that the designed curve-mold geometry is effectively transferred to the PDMS lenses. This performance meets the clinically required range for canine pseudophakic correction. A key advantage of this fabrication approach is that optical power can be controlled through a single geometric parameter, enabling the production of patient-specific lenses spanning 18 to 42 D without modifying the material system or processing conditions. This flexibility is especially relevant for addressing variations in axial eye length and corneal curvature across different canine breeds.

To further evaluate the image-forming performance of the fabricated PDMS IOL, a USAF 1951 resolution target was employed as shown in Figure 7E. Representative images acquired through the commercial IOL and the fabricated PDMS IOL are shown in Figures 7F and 7G, respectively. Both lenses successfully resolved group 4, element 2, corresponding to a spatial frequency of 20.16 line pairs/mm, which was the highest spatial-frequency target evaluated in this study. Image contrast was quantified using the Michelson contrast (C).

C=Imax−IminImax+Imin

where Imax and Imin are the maximum and minimum intensity, respectively. The fabricated PDMS IOL exhibited a Michelson contrast of 40.6 ± 1.05%, which was comparable to that of the commercial IOL (41.2% ± 1.55%). These results demonstrate that the fabricated PDMS IOL preserves fine spatial features while maintaining image contrast comparable to that of a commercial IOL under the tested imaging conditions.

Imaging performance

To demonstrate real-image formation, a PDMS lens was fabricated with a larger curvature radius (R = 20 mm) to provide a longer focal length suitable for bench-top imaging in air. The lens was mounted in a 3D-printed holder directly in front of the image sensor of a Sony NEX-5T APS-C camera with the camera lens removed, forming a bare-sensor imaging configuration. Four scenes were captured at different object distances, as shown in Figure 8, alongside reference images captured using a smartphone under similar lighting conditions.

[图:Comparison of imaging performance The fabricated PDMS IOL (top) and a smartphone reference (bottom).]

论文配图

The PDMS IOL produced clearly recognizable images with distinguishable shapes, colors, and text. Color fidelity was preserved, consistent with the high optical transparency reported in Section 3.3. No visible haze or significant scattering was observed, confirming that the fabricated lens surfaces are suitable for image-forming applications. This qualitative experiment confirmed that the fabricated PDMS intraocular lenses can function as effective image-forming elements.

Surface wettability

Surface wettability was evaluated to assess the interfacial properties of the fabricated PDMS intraocular lenses, which can influence interactions with the ocular environment. Static water contact angles were measured as 110.59 ± 4.81°, 114.58 ± 5.14°, and 108.32 ± 3.20° for PDMS IOLs prepared at base-to-curing-agent ratios of 10:1, 15:1, and 20:1, respectively, as shown in Figures 9A–9C, indicating consistently hydrophobic surfaces. These values are consistent with the intrinsic hydrophobicity of crosslinked PDMS and are comparable to those of silicone-based intraocular lenses.7,31

[图:Static water contact angle measurements of fabricated PDMS intraocular lenses (A) 10:1, (B) 15:1, and (C) 20:1 base-to-c]

论文配图

Mechanical properties

The mechanical properties of the fabricated PDMS intraocular lenses were first evaluated under compressive loading using a tensile tester (EZ-5, Shimadzu, Japan). This test assessed whether the lenses retained adequate structural stability while maintaining sufficient flexibility for folding during implantation. The results, including maximum compressive stress, strain, and elastic modulus, are summarized in Table 2. The maximum compressive stress was similar across all formulations, remaining around 22 MPa. In contrast, the elastic modulus decreased with increasing base-to-curing-agent ratio, with an overall reduction of approximately 49% from 10:1 to 20:1. Correspondingly, the maximum compressive strain increased, indicating greater flexibility at higher base ratios. These results show that the compressive mechanical response of the fabricated lenses can be tuned by adjusting the PDMS base-to-curing-agent ratio.

Table 2. Compression properties of fabricated PDMS IOLs at different base-to-curing-agent ratios

Table 2 Compression properties of fabricated PDMS IOLs at different base-to-curing-agent ratios
PDMS base-to-curing ratioMax stress (MPa)Max strain (%)Elastic modulus (N/mm 2 )
10:122.23 ± 0.0184.79% ± 2.980.97 ± 0.33
15:122.24 ± 0.0292.99% ± 0.730.91 ± 0.03
20:122.23 ± 0.0299.25% ± 0.890.50 ± 0.16

Although compression testing provides information on bulk mechanical behavior, implantation of a foldable intraocular lens also involves substantial shear deformation as the lens passes through the injector cartridge. Therefore, oscillatory shear rheological measurements were additionally performed to evaluate the viscoelastic response of the fabricated PDMS IOLs under implantation-relevant deformation.

To further evaluate the viscoelastic properties of the fabricated PDMS intraocular lenses under implantation-relevant shear deformation, oscillatory rheological measurements were performed using a rheometer (HAAKE MARS 40, Thermo Fisher Scientific, Germany) in shear mode at 37°C and 1 Hz. The representative rheological parameters are summarized in Table 3. At low strain, all PDMS formulations exhibited storage modulus (G′) values higher than loss modulus (G″), indicating predominantly elastic behavior. The 10:1 formulation exhibited the highest initial G′ (61.06 kPa), followed by the 15:1 (53.48 kPa) and 20:1 (24.44 kPa) formulations, reflecting the higher crosslink density associated with increasing curing-agent content. In the high-strain region (approximately 50%–60% strain), the 15:1 formulation retained the highest G′ (27.97 kPa), compared with 13.20 kPa and 15.91 kPa for the 10:1 and 20:1 formulations, respectively. The 15:1 formulation also exhibited the highest G″ (15.35 kPa) in this region, indicating a balanced viscoelastic response under large deformation, with the ability to maintain its structure while dissipating deformation energy. Together with the compression analysis, these findings demonstrate that the mechanical behavior of the fabricated PDMS IOLs can be tailored by adjusting the base-to-curing-agent ratio.

Table 3. Oscillatory shear rheological properties of fabricated PDMS intraocular lenses at different base-to-curing-agent ratios

Table 3 Oscillatory shear rheological properties of fabricated PDMS intraocular lenses at different base-to-curing-agent ratios
PDMS ratioInitial G′ (kPa)Initial G″ (kPa)G′ at 50–60% strain (kPa)G″ at 50–60% strain (kPa)
10:161.065.6313.2015.21
15:153.484.6827.9715.35
20:124.443.2015.915.96

These results show that the mechanical response of PDMS IOLs can be adjusted through the base-to-curing-agent ratio. Although the 15:1 formulation provided the most stable shear response at high strain, the 10:1 formulation remains the most suitable candidate among the tested formulations when both mechanical performance and cytocompatibility are considered.

To further assess the practical deformation response of the selected 10:1 PDMS IOL during implantation, an injector-delivery demonstration was performed using a standard commercial IOL injector cartridge as shown in Figure 10, the fabricated plate-haptic PDMS IOL was first loaded into the injector cartridge, positioned within the loading chamber, folded prior to delivery, and subsequently delivered through the injector. Following injector-assisted delivery, the lens recovered its overall plate-haptic geometry without visible cracking, tearing, or gross structural damage, demonstrating its ability to tolerate the combined compression, folding, shear, and frictional stresses encountered during the implantation process. The complete injector-assisted delivery procedure is provided in Video S1.

[图:Injector-assisted delivery of the fabricated PDMS intraocular lens (A) Fabricated PDMS IOL before loading into a standar]

论文配图

[内容请查看原文]

In vitro cytotoxicity

To ensure the suitability of the fabricated PDMS intraocular lenses for implantation, their biocompatibility was evaluated through in vitro cytotoxicity testing. For each PDMS formulation, five fabricated lenses (n = 5) were used for extract preparation. Extracts were prepared in accordance with ISO 10,993–12. Cell viability was interpreted according to ISO 10,993–5 guidance, where cell viability below 70% is considered indicative of a cytotoxic effect under the tested extract conditions.32 Cell viability results for the different PDMS formulations are presented in Figure 11.

[图:In vitro cytotoxicity of fabricated PDMS intraocular lenses before and after post-treatment Cell viability was evaluated]

论文配图

As shown in Figure 11, the control group showed 100.00% cell viability. Among the PDMS formulations, the 10:1 base-to-curing-agent ratio showed 83.97% ± 15.35% cell viability, exceeding the 70% threshold and indicating acceptable cytocompatibility. In contrast, the 15:1 and 20:1 formulations showed lower cell viability values of 57.61% ± 8.17% and 60.48% ± 5.13%, respectively, suggesting potential cytotoxic effects under the tested conditions. The observed differences among formulations are attributed to the presence of residual uncrosslinked PDMS oligomers. At higher base-to-crosslinker ratios, reduced crosslinking leads to a greater fraction of low-molecular-weight chains in the network. These oligomers can interact with cell membranes and induce cytotoxic responses,33 which is consistent with the lower viability observed for the 15:1 and 20:1 formulations.

Following post-treatment by rinsing with isopropyl alcohol (IPA) and deionized (DI) water, all formulations exhibited cell viabilities above the ISO 10,993–5 acceptance criterion (70%), with values of 97.78% ± 3.29%, 99.68% ± 11.48%, and 86.19% ± 10.73% for the 10:1, 15:1, and 20:1 formulations, respectively. These results indicate that the initial reduction in cell viability was primarily associated with removable extractable residues or uncured surface components rather than the cured PDMS network itself.

Hydrolytic stability test

The hydrolytic stability test was performed in accordance with ISO 11,979-534 to evaluate the stability of PDMS IOLs under accelerated aqueous aging. Samples were incubated in BSS at 95°C for 30 days, corresponding to approximately five years of physiological aging.34 After accelerated aging, the PDMS IOLs maintained their overall lens structure, although localized surface alterations, including pitting-like features, dark deposits/discoloration, and line-like surface defects, were observed as shown in Figure 12. In addition, the visible-light transmittance of the aged PDMS IOLs remained 80.94% ± 11.91%, which was comparable to that of the commercial IOL (82.27%), indicating that the optical transparency was largely preserved following accelerated hydrolytic aging. These results indicate preliminary structural stability of the fabricated PDMS IOLs after five-year equivalent hydrolytic aging, although further long-term stability testing remains necessary before clinical application.

[图:Confocal microscopy images of the fabricated PDMS intraocular lens (A) before and (B) after accelerated hydrolytic aging]

论文配图

Leachability test

The leachability test was performed in accordance with ISO 11,979–5 to evaluate potential compounds released from PDMS IOLs under simulated extraction conditions. Samples were extracted in distilled water, BSS, and toluene at 37°C for 72 h to represent aqueous and lipophilic extraction environments. The extracted PDMS IOLs maintained high optical transmittance after exposure to all extraction media. The visible-light transmittance remained 91.85% ± 11.47%, 99.09% ± 4.99%, and 96.75% ± 8.97% following extraction in DW, BSS, and toluene, respectively, with no statistically significant differences among the extraction media (p = 0.47). Furthermore, the extraction media exhibited consistently low UV-vis absorbance without distinct absorption peaks, indicating minimal evidence of UV-vis-detectable leachable compounds under the extraction conditions investigated. These findings suggest that the fabricated PDMS IOLs maintained their optical properties after extraction in both aqueous and lipophilic media while exhibiting minimal release of UV-vis-detectable leachable species.

Limitations of the study

The fabricated PDMS IOL presented in this work is intended as a prototype demonstrating the feasibility of a customizable fabrication platform rather than as a replacement for commercially available intraocular lenses. Compared with a commercial IOL, the fabricated PDMS IOL demonstrated comparable preliminary performance in several evaluations performed in this study, including image resolution, Michelson contrast, optical transparency following accelerated hydrolytic aging, and injector-assisted delivery. Nevertheless, several important challenges remain before clinical application, including further optimization of surface quality, long-term mechanical durability under cyclic loading, comprehensive biological evaluation, and in vivo validation. Despite these limitations, the proposed fabrication strategy enables rapid digital customization of lens geometry without dedicated tooling. Reusable molds allow repeated PDMS casting with tunable optical power (18–42 D) through simple geometric modification, facilitating rapid design iteration and providing a practical platform for producing patient-specific intraocular lenses. Overall, this work establishes a customizable and scalable fabrication platform for PDMS-based intraocular lenses and provides a foundation for the future development of ophthalmic implants.

Resource availability

Lead contact

Requests for further information and resources should be directed to and will be fulfilled by the lead contact, Charusluk Viphavakit (charusluk.v@chula.ac.th).

Materials availability

This study did not generate new unique reagents.

Data and code availability

  • [内容请查看原文]

    Data reported in this paper will be shared by the lead contact upon request.

  • [内容请查看原文]

    This paper does not report original code.

  • [内容请查看原文]

    Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

  • Acknowledgments

    This research is financially supported by the Second Century Fund (C2F), Thailand Science research and Innovation Fund Chulalongkorn University (IND_FF_69_091_2100_014), 111th Anniversary Engineering Research Catalyst Fund Toward U Top 100 (038/2569), National Research Council of Thailand (NRCT), and Chulalongkorn University (N42A690579), Rachadapisek Sompote Fund for Biomedical Materials and Devices for Revolutionary Integrative Systems Engineering Research Unit (BMD-RISE), Chulalongkorn University, Thailand.

    Author contributions

    S.R. writing – original draft, validation, methodology, investigation, formal analysis, data curation; A.C. data curation; T.L. data curation; N.T., O.J., and S.K.M. supervision, writing – review and editing; C.V. writing – review and editing, supervision, project administration, methodology, funding acquisition, conceptualization.

    Declaration of interests

    The authors declare no competing interests.

    STAR★Methods

    Key resources table

    REAGENT or RESOURCESOURCEIDENTIFIER
    Biological sample
    L929 mouse fibroblast cellsATCC, USANCTC clone 929 CCL-1
    Chemicals
    PDMSDow Corning/Dow, USASylgard 184 PDMS kit
    Polymethyl methacrylate (PMMA)Sigma-Aldrich/Merck, Germany182265
    UV-curable resinElegoo, China8K standard resin
    Software and algorithms
    CAD softwareOnshape, USAOnshape.com
    Slicer softwareElegoo, ChinaChitubox
    Image processing softwareImagJFiji
    Other
    Commercial soft acrylic IOLAJL Ophthalmic S.A., SpainLiocan foldable canine IOL
    LCD 3D printerElegoo, ChinaMars 5 Ultra
    RheometerThermo Fisher ScientificHAAKE MARS 40
    Tensile testerShimadzu, JapanEZ-5
    UV/Vis spectrophotometerPerkinElmer, USALambda 850+
    Raman spectroscopyHoriba, JapanXplora plus
    Confocal laser scanning microscopeOlympus Corporation, JapanOLS5100
    CMOS cameraHayear, ChinaHY-500M
    Fiber-coupled LEDThorlabs, USAM530F3

    Method details

    Mold fabrication and surface preparation

    Molds were fabricated using an Elegoo Mars 5 Ultra LCD stereolithography printer (Elegoo, China) operating at 405 nm with an 18 μm pixel resolution and UV photopolymer resin (8K standard resin, Elegoo, China). After printing, the molds were cleaned by sequential immersion in ethanol to remove residual uncured resin. A thin layer of UV-curable resin was spin-coated onto the mold surface at 1,000 rpm for 60 s to reduce surface roughness arising from the layer-by-layer printing process. The molds were subsequently UV post-cured for 1 h and thermally treated at 100°C for 1 h to complete photopolymerization and remove residual photoinitiator.

    PMMA barrier coating

    Following surface preparation, a PMMA barrier layer was applied to the mold surface to prevent curing inhibition of the PDMS. A 4% (w/w) PMMA solution in anhydrous toluene was spin-coated onto the mold at 1,000 rpm for 30 s, followed by thermal treatment at 100°C for 30 min.

    PDMS casting and curing

    PDMS lenses were fabricated using Sylgard 184 at base-to-curing-agent ratios of 10:1, 15:1, and 20:1 (w/w). Each formulation was thoroughly mixed and vacuum-degassed (<600 mmHg) for 1 h to remove entrapped air. The PDMS precursor was then cast into the assembled mold cavity and thermally cured in a convection oven at 100°C for 2 h. After cooling to room temperature, the lenses were carefully demolded and prepared for subsequent characterization.

    Cytotoxicity testing

    In vitro cytotoxicity testing was performed using L929 mouse fibroblast cells at the Biomaterial Testing Center, Faculty of Dentistry, Chulalongkorn University. Five fabricated lenses from each PDMS formulation were used for extract preparation. For the post-treatment group, fabricated lenses were rinsed with isopropyl alcohol for 1 min followed by deionized water for 1 min before extraction. Cell viability was interpreted according to ISO 10993–5, where a reduction in cell viability of more than 30% relative to the control was considered indicative of cytotoxicity.

    Hydrolytic stability testing

    Hydrolytic stability testing was performed according to ISO 11979-5. Fabricated PDMS IOLs were incubated in BSS at 95°C for 30 days, corresponding to approximately five years of physiological aging. PDMS IOLs were extracted in 3 mL BSS, while commercial IOL controls were extracted in 0.3 mL BSS. After aging, lens morphology was evaluated by confocal microscopy at 100× magnification and compared with commercial IOLs under the same aging condition.

    Leachability testing

    Leachability testing was performed according to ISO 11979–5. Fabricated PDMS IOLs were extracted in distilled water, BSS, and toluene at 37°C for 72 h. PDMS IOLs were extracted in 3 mL of each medium, while commercial IOL controls were extracted in 0.3 mL of each medium. Solvent blanks were prepared under the same conditions. After extraction, the extraction media and extracted lenses were analyzed by UV/Vis spectrophotometry from 300 to 900 nm. The extraction media were assessed for UV/Vis-detectable leachable compounds, while the extracted lenses were evaluated for changes in optical transparency.

    Quantification and statistical analysis

    Quantitative data are reported as mean ± standard deviation (SD), unless otherwise stated. The number of replicates (n) is indicated in the corresponding figure legends, table captions, or method descriptions. For optical power measurements, n represents independently fabricated lenses measured at each curvature radius, whereas for cytotoxicity testing, n represents independently fabricated lenses used for extract preparation for each PDMS formulation. For other measurements, n represents independent samples or repeated measurements, as specified in the corresponding sections.

    Footnotes

    [内容请查看原文]

    References

    [内容请查看原文]

    Associated Data

    Supplementary Materials

    [内容请查看原文]

    Data Availability Statement

  • [内容请查看原文]

    Data reported in this paper will be shared by the lead contact upon request.

  • [内容请查看原文]

    This paper does not report original code.

  • [内容请查看原文]

    Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

  • 本文为开放获取(Open Access)文章,全文转载自 Europe PMC,遵循原许可协议(cc by-nc); 来源:iScience · DOI: 10.1016/j.isci.2026.117890,版权归原作者及出版方所有;中文为机器翻译,临床术语以英文原文为准。 查看原文 ↗

    跳转原文 ↗ 返回列表

    快捷键 S 一键收藏本文,收藏内容在 我的收藏 查看;PubMed 位于境外,直接访问原文可能需要国际网络环境,站内摘要无需翻墙即可阅读。

    采集时间:2026-10-27 03:01:15 · 中文解读将在编辑审核后另行发布,未经审核的自动标注不构成临床依据。